Trial
NCT05254613
A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Healthy
Intervention
ALXN1830
Why stopped
The justification of the early termination of the trial: the study is early terminated due to the Coronavirus 2019 epidemic.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-22